Sheila Henry
Psychiatric/Mental Health · New York, NYNPI 1639593361
Payments from drug & device makers
Across 182 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$525
- AbbVie$520
- Teva Pharmaceuticals USA, Inc.$427
- Otsuka America Pharmaceutical, Inc.$415
- Alkermes, Inc.$294
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$292
- plus $892 from 7 others
What the payments were for
- Food & beverage$3,23996%
- Education$1274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $525 |
| AbbVie | 29 | $520 |
| Teva Pharmaceuticals USA, Inc. | 31 | $427 |
| Otsuka America Pharmaceutical, Inc. | 23 | $415 |
| Alkermes, Inc. | 12 | $294 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $292 |
| Neurocrine Biosciences, Inc. | 12 | $256 |
| Vanda Pharmaceuticals Inc. | 13 | $244 |
| Indivior Inc. | 7 | $154 |
| E.r. Squibb & Sons, L.L.C. | 4 | $104 |
| Sunovion Pharmaceuticals Inc. | 4 | $76 |
| Noven Therapeutics, LLC | 2 | $41 |
| Lundbeck LLC | 1 | $18 |
How this compares
$3,366 in reported general payments places this provider in the 85th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 46 | $152,907 |
| Abilify MaintenaAripiprazole | 16 | $44,688 |
| VraylarCariprazine Hcl | 29 | $43,843 |
| PerserisRisperidone | 12 | $30,765 |
| Aripiprazole | 135 | $5,838 |
| Clozapine | 24 | $1,972 |
| Fluphenazine Hcl | 19 | $1,871 |
| Duloxetine Hcl | 71 | $1,353 |
| Olanzapine | 59 | $1,042 |
| Lamotrigine | 78 | $1,007 |
| Divalproex Sodium ErDivalproex Sodium | 27 | $980 |
| Quetiapine Fumarate | 92 | $937 |
| Hydroxyzine Pamoate | 106 | $874 |
| Risperidone | 79 | $859 |
| Mirtazapine | 73 | $834 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $525 | $152,90746 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $415 | $44,68816 claims |
| AbbVieVraylar | $520 | $43,84329 claims |
| Indivior Inc.Perseris | $154 | $30,76512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in New York
- Mary OlsonNew York$142K
- Richard CalladoNew York$47K
- Darcy LeonNew York$37K
- Angela AnukamNew York$11K
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.